ACCESSIBILITY

24/7

Headlines

15:36

Israel to invest over $30M in groundbreaking lab for bio-devices and biochips development

15:32

"People worry AI will replace them, but those who master it will thrive"

15:24

War games of a different kind: Games developed in this war have a higher purpose

15:11

"AI will not replace game developers - it will make their lives easier"

Buzz

Most popular

Daily

Weekly

Have missiles from the Iranian-backed Houthis discovered a loophole in Israeli air defenses?

Windward acquired for $270M by FTV Capital, doubling its IPO valuation

$41B in exits: Why Israeli cyber startups are a global powerhouse

Kaltura CEO: "Just like a missile hit our office, a missile hit us with the IPO"

Israeli fintech Morning acquired for $150 million by Italy's TeamSystem

More news

Pharmaceuticals

20 stories about Pharmaceuticals

Berkshire Hathaway Takes Position in Generic Drugmaker Teva

15.02.18|Lilach Baumer

The holding company disclosed a $358 million stake in the struggling company

Teva Gets Fresh Cash, Fresh Woes

04.02.18|Dror Reich

After the troubled drugmaker finalized two deals that will enable it to repay some of its debt, S&P placed it on CreditWatch negative on Friday

As Part of Cost-Cutting Plan, Teva Will Shut Down Twenty or More Manufacturing Sites

10.01.18|Lilach Baumer

The drugmaker will shut down 20-25 manufacturing sites in the next two years, CEO Kåre Schultz said Monday

As U.S. Domestic Issuer, Teva Reveals Top Stock Owners

03.01.18|Dror Reich

Kåre Schultz, the newly-appointed CEO of generic drugmaker Teva Pharmaceutical Industries Ltd., is one of Teva's largest shareholders, a Wednesday filing to the U.S. Securities and Exchange Commission revealed

שם: מעבדה ביוטק וושי אפטק Lab Biotech WuXi AppTec

Merck, China’s WuXi AppTec to Launch Biotech Incubator in Israel

25.12.17|Meir Orbach

Israel-born businessman Mori Arkin and life sciences-focused venture capital fund Pontifax are also partners in the venture, set to launch in 2018

Following Restructuring Announcements, Teva Reinstated as Israel’s Biggest Company

18.12.17|Lilach Baumer

Teva's stock jumped 18.7% on the New York Stock Exchange between Thursday market opening and Friday market close. Israeli Prime Minister Benjamin Netanyahu is expected to meet with CEO Kåre Schultz Tuesday

אחרי ה שביתה נתב"ג טבע פיטורים טיסות טרמינל

Tel Aviv Airport, Stock Market Open as Solidarity Strike Ends

17.12.17|Lior Gutman, Omri Milman and Micky Grunfeld

Israel’s largest labor union called for a half-day strike on Thursday, in support of Teva employees

Once Future CEO Could have Taken Teva on a Different Path

14.12.17|Lilach Baumer, Golan Hazani, and Orr Hirschauge

AstraZeneca CEO Pascal Soriot, which backed out of Teva’s CEO position in July, planned on taking the company towards innovation instead of generic focus

Teva to Cut Around Half of Israeli Workforce, Outsource Operations

13.12.17|Dror Reich

An internal document reviewed by Calcalist reveals the troubled drugmaker's detailed domestic cost-cutting plans

Teva to Cut Jobs, Shut Down Some Israeli Operations

13.12.17|Dror Reich and Sefi Krupsky

On Thursday, the troubled drugmaker is expected to unveil its cutback plan. At its center is extensive layoffs and the reorganization and divestment of non-core assets

Former Chairman Yitzhak Peterburg Leaves Teva

13.12.17|Lilach Baumer

Mr. Peterburg was the troubled drugmaker's interim CEO between February and November 1, when Kåre Schultz took helm

Teva to Unveil Strategic Plan, Layoffs Thursday

12.12.17|Dror Reich

Last month the debt-riddled drug maker announced a rehabilitation plan amidst rumors of upcoming employee cuts

Gilead Builds on Kite Pharma Acquisition, Buys Second CAR-T Therapy Company

10.12.17|Lilach Baumer

California-based Cell Design Labs will be acquired in a deal valued at up to $567 million

Fresh Teva Lawsuit Goes Against Dividends Paid by Debt Heavy Drugmaker

30.11.17|Anat Rouah

Tel Aviv-based capital investment firm Tulip Capital is threatening derivative action against Teva, saying the company's huge debt load renders its dividends unlawful

New CEO Steers Teva Back to Generics

28.11.17|Golan Hazani and Dror Reich

A reorganization plan announced by the company Monday would see the troubled drugmaker return to its core competencies, despite market pressures

Biomed Company Protalix to Lay Off a Fifth of its Workforce

26.11.17|Dror Reich

The Israel-based NYSE American-listed company is currently undergoing a streamlining process

Cannabis Breeder Barney's Farm Invests in Israeli Cannabis Company

23.11.17|Dror Reich

Barney's made a strategic investment of $2.1 million in Tel Aviv-listed Medivie Therapeutic Ltd., a company setting up a medical cannabis farm and pharmacy venture

Perrigo Completes Sale of Israel Business for $110 million

23.11.17|Lilach Baumer

The buyer, New York-based investment firm SK Capital, has $1.9 billion assets under management

Troubled Drugmaker Teva to Axe over 4,000 Jobs

23.11.17|Golan Hazani

Less than a month after stepping in as CEO, Kåre Schultz starts tightening the belt. The company is expected to oust Chief Scientific Officer Michael Hayden

Investors Cheer as Mylan Plans to Delist from Israeli Stock Exchange

12.11.17|Uri Tal-Tenne and Dror Reich

Mylan is currently the highest valued company on the TASE at $18.5 billion

Previous Articles More Articles